Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074). (Q43181709)
Jump to navigation
Jump to search
scientific article published in February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074). |
scientific article published in February 2010 |
Statements
1 reference
Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074). (English)
1 reference
Olivier Rixe
1 reference
Patricia Pautier
1 reference
Florence Joly
1 reference
Pierre Kerbrat
1 reference
Philippe Bougnoux
1 reference
Pierre Fumoleau
1 reference
Thierry Petit
1 reference
François Ringeisen
1 reference
Annie Tisseron Carrasco
1 reference
Catherine Lhommé
1 reference
1 February 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference